Founded in 2002 by spine surgeons and geneticists, Axial Biotech is developing DNA-based tests and motion-preserving technologies for spinal disorders. Their first product, ScoliScore, is a diagnostic test that predicts spinal curve progression in patients with adolescent idiopathic scoliosis. Axial Biotech aims to expand the treatable scoliosis patient population and apply their gene discovery methodology to other spinal diseases.